Cirrhosis of the Liver with Resulting Hepatic Encephalopathy By: Michelle Hoffman

Embed Size (px)

Citation preview

  • Slide 1
  • Cirrhosis of the Liver with Resulting Hepatic Encephalopathy By: Michelle Hoffman
  • Slide 2
  • Patient Teresa Wilcox Physician: P. Horowitz, MD Education: doctoral graduate student Age: 26-years-old Height: 59 (1.7 m) Current Weight: 125 lbs (56.8 kg) Usual Body Weight: 145 lbs BMI:18.5 kg/m^2 Underweight Dx: Probable cirrhosis secondary to chronic hepatitis 2
  • Slide 3
  • Patient History Hepatitis C Dx 3 years ago Complaints of fatigue, anorexia, N/V, weakness Lost 10 lbs since last visit 6 months ago Bruising and yellowish skin Family hx cirrhosis (grandfather) 3
  • Slide 4
  • Physical Exam Tired in appearance Enlarged esophageal veins Warm and dry skin with bruising on lower arms and legs Normal muscular tone and ROM No edema or ascites 4
  • Slide 5
  • Nutrition History Has not an an appetite for last few weeks Has not eaten in the last 2 days Nutrition therapy of small, frequent meals with plenty of liquids 3 years ago Breakfast: calcium-fortified orange juice Lunch: soup and crackers with diet coke Dinner: Chinese or Italian carry-out Fluids: small sips of water, diet coke, or juice Does not consume alcohol Current diet order: Soft, 4-g Na, high-kcal 5
  • Slide 6
  • Abnormal Chemistry Albumin Normal: 3.5-5 g/dL Ms. Wilcox: 2.1 g/dL Total protein Normal: 6-8 g/dL Ms. Wilcox: 5.4 g/dL Bilirubin Normal: 0.3 mg/dL Ms. Wilcox 3.7 mg/dL 6
  • Slide 7
  • Abnormal Hematology RBC Normal: 4.3-5.4 Ms. Wilcox: 4.1x10^6/mm^3 HGB Normal: 12-15 g/dL Ms. Wilcox: 10.9 g/dL HCT (hematocrit) Normal: 37-47% Ms. Wilcox: 35.9% 7
  • Slide 8
  • Abnormal Hematology MCV (mean cell volume) Normal: 80-96 m^3 Ms. Wilcox: 102 m^3 Ferritin (protein that stores iron) Normal: 20-120 mg/mL Ms. Wilcox: 18 mg/mL PT (prothrombin time) Normal: 11-16 sec Ms. Wilcox: 18.5 sec 8
  • Slide 9
  • Diagnosis Cirrhosis 12 th leading cause of death in the U.S. Ending stage of liver disease Secondary to chronic hepatitis C Replacement of healthy liver tissue with scar tissue Blocks the flow of blood through the liver, causing kidney failure, enlarged liver, thickening of various tissues, portal hypertension, ascites, etc. 9
  • Slide 10
  • Diagnosis 10
  • Slide 11
  • 11
  • Slide 12
  • Etiology Common causes of cirrhosis: Alcohol-related liver disease Chronic hepatitis C Chronic hepatitis B Autoimmune hepatitis Nonalcoholic fatty liver disease (NAFLD) Bile duct disorders Hereditary disorders 12
  • Slide 13
  • Symptoms Weakness Fatigue Loss of appetite N/V Weight loss Abdominal pain and bloating Itching 13
  • Slide 14
  • Complications & Warning Signs Edema &Ascites Bruising and bleeding Portal hypertension Esophageal varices Jaundice Hepatic encephalopathy Insulin resistance and type II diabetes 14
  • Slide 15
  • Ascites 15
  • Slide 16
  • Diagnosing Cirrhosis Look at the clinical signs & symptoms Biopsy, CT Scan, and MRI may reveal an enlarged liver, reduced blood flow, and /or ascites Biopsys are less common because it it expensive, and usually only confirms a diagnosis 16
  • Slide 17
  • Diagnosing Cirrhosis Blood tests to measure: Measures function of the liver Albumin Bilirubin PT (Prothrombin Time) Liver enzymes: Measures injury to the liver ALT AST 17
  • Slide 18
  • Severity MELD Model for end-stage liver disease 6 - 40 score range6 is a likelihood that patient will survive 90 days Score comes from: Bilirubin countmeasures bile pigment in the blood Creatine levelstests kidney function INR (international normalizes ratio)tests blood clotting tendency 18
  • Slide 19
  • Treating Cirrhosis Primary medical treatments for cirrhosis: Preventing further damage Treatment of the complications Liver transplant Nutrition therapy 19
  • Slide 20
  • 20 Treating Cirrhosis Preventing further damage: The first thing doctors will recommend is abstaining from alcohol and any drugs that will damage the liver further Consume a balanced diet and a multivitamin may be recommended (D and K especially) Avoid nonsteriodalantinflammatory drugs (NSAIDS) Ibuprofen
  • Slide 21
  • 21 Treating Cirrhosis Treating complications: Ascites Antidiuretics Bleeding from varices Beta-blockers Propanolol Hepatic Encephalopathy Laxatives (lactulose)
  • Slide 22
  • 22 Treating Cirrhosis Liver Transplant: Cirrhosis in irreversible, and many patients will eventually need a liver transplant as the only option left 80% of patient live for 5 years after surgery
  • Slide 23
  • Nutrition Therapy Recommendation Kcals 35-40 kcal/kg Protein 1.6 g/kg/day Fat 30% of calories/day CHO 50-60% of calories/day Sodium No more than 2-g/day Fluid 1.2-1.5 L/day Calcium1,000-1,500 mg Vitamins May need multivitamin supplement; see doctor 23
  • Slide 24
  • 24 Energy & Protein Ms. Wilcoxs energy needs: Weight: 56.8 kg 35 x 56.8= 1,988 calories 40 x 56.8= 2,272 calories 2,000-2,200 calories/day. Ms. Wilcoxs protein needs: 1.6 x 56.8=90.8 ~ 91 g protein/day
  • Slide 25
  • 25 Nutrition Problems Inadequate energy intake: NI-1.4 Inadequate oral intake: NI-2.1 Malnutrition: NI-5.2 Inadequate protein-energy intake: NI-5.3 Underweight: NC-3.1
  • Slide 26
  • 26 PES Statements Inadequate energy intake related to decreased appetite, fatigue, and nausea by recent cirrhosis of the liver dx as evidenced and diet recall Underweight related to decreased appetite in past three weeks as evidenced by diet recall, recent 10 lb weight loss, and BMI of 18.5 kg/m^2
  • Slide 27
  • 27 Nutrition Intervention & Support Small frequent feedings Encourage oral liquid supplements High kcal and protein diet Restrict sodium intake to 2-g Abstain from alcohol consumption Provide foods that are easy to chew and swallow Optimize gastric emptying Avoid excessive fiber Control blood glucose Liquids over solids if necessary
  • Slide 28
  • 28 Prognosis Depends on stage of the disease Once the liver has scarred over, it cannot be reversed, meaning it cannot return to its normal function Survival is generally 10 years after dx (90%) Complications of ascites, portal hypertension, jaundice, hepatorenal syndrome, hepatic encepalopathy, etc. Liver transplant will most likely be needed as a result of cirrhosis
  • Slide 29
  • 29 Prognosis: Stages of Cirrhosis Stage 1 Patients without gastro-esophageal varices or ascites have mortality of ~1% per year Stage 2 Patients with gastro-esophageal varices but no ascites have mortality of ~4% per year Stage 3 Patients without gastro-esophageal varices but have ascites have mortality rate of ~20% per year Stage 4 Patients with GI bleeding from portal hypertension with/without ascites have mortality of ~57% per year
  • Slide 30
  • 30 References Nelms, M., Sucher, K. P., Lacey, K., & Roth, S. L. (2011). Nutrition Therapy and Pathophysiology. Belmont, California: Wadsworth, Cengage Learning. "Prognosis." Best Practice. BMJ Group, 14 June 2012. Web. 11 Nov. 2012.. Longstreth, George F. "Cirrhosis: MedlinePlus Medical Encyclopedia." Medline Plus. U.S. National Library of Medicine, 16 Oct. 2011. Web. 11 Nov. 2012.. Lee, Dennis. "Cirrhosis (Liver) Symptoms, Causes, Treatment - How Is Cirrhosis Treated? on MedicineNet." MedicineNet. N.p., 2012. Web. 11 Nov. 2012.. "Cirrhosis." Cirrhosis. University of Maryland Medical Center, 2011. Web. 11 Nov. 2012.. "National Digestive Diseases Information Clearinghouse (NDDIC)." Cirrhosis. N.p., Dec. 2008. Web. 11 Nov. 2012.. "Learning About Your Health." Cirrhosis of the Liver. CPMC Sutter Health, 2012. Web. 11 Nov. 2012..